Trials / Completed
CompletedNCT01501331
Multiparametric Heart Failure Evaluation in Internal Cardioverter Defibrillators (ICD) Patients
Multiparametric Evaluation of Heart Failure in Device-implanted Patients.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 180 (estimated)
- Sponsor
- University of Rome Tor Vergata · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The Boston Scientific Energen family is capable of measuring the respiratory rate trend (RRT) on a daily basis and transmission of data via the Remote Monitoring technology. This may result in early detection of imminent decompensation at a presymptomatic stage. The study will assess the respiratory trends correlation with clinically relevant heart failure events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CRTD or ICD (Energen) | RRT measurement by cardiac resynchronization therapy devices and implantable cardioverter defibrillators |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2011-12-29
- Last updated
- 2014-11-18
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT01501331. Inclusion in this directory is not an endorsement.